Healthcare facilities currently using VOCSN V+Pro ventilators must take immediate action following the FDA’s Class I recall announcement. The critical oxygen leak defect poses direct threats to patient safety, making swift verification and removal of affected devices essential.
Three key priorities for healthcare providers include: (1) conducting immediate serial number verification to identify affected VOCSN V+Pro units in their facilities, (2) discontinuing use of confirmed affected devices to prevent undetected oxygen delivery failures, and (3) implementing corrective action protocols to address the manufacturing defect before resuming operations. Inadequate oxygen delivery resulting from undetected leaks can rapidly progress to hypoxemia and respiratory failure in critically ill patients.
The Centers for Disease Control and Prevention emphasizes that proper ventilator function is essential for patient outcomes in intensive care settings. Healthcare administrators should communicate this recall to all relevant departments and ensure staff understand the importance of device verification procedures. Facilities are encouraged to contact React Health and the FDA for additional guidance on remediation.
Read the full article on GMJ Newsroom.
Was this article helpful?
